<?xml version="1.0" encoding="UTF-8"?>
<p id="p0075">We enrolled 151 patients in the study between December 2006 and February 2011. The study was suspended because of slow accrual and poor end points in the ICT/CCRT arm during interim analysis. Seventy-seven patients were assigned to the ICT/CCRT arm and 74 patients to the CCRT arm (
 <xref rid="fig1" ref-type="fig">Fig. 1</xref>). Most patients were men and relatively young. The ECOG performance status was 0–1 in 95.4% patients. Primary sites included the hypopharynx 49.0%, oropharynx 41.1%, and larynx 9.9%, and of the patients, 55.6% had T4 stage tumors, 10.6% had N3 stage disease, 92.1% had stage IV disease, and 23.8% had unresectable disease.
</p>
